I would also suggest that Jane Shaw as a founder does not want her shareholding unnecessarily diluted.
I would imagine she would expect the shareprice to be susbtantially higher once accrediation from NATA (hopefully by mid year ) has been received and the test can then be commercially rolled out in Australia. Upon that milestone it would be fairly easy to raise capital at multiples of the current share price.
BCal does not need TGA approval interestingly.
- Forums
- ASX - By Stock
- Ann: $2.4m Capital Raise to Further BREASTEST Commercialisation
BDX
bcal diagnostics limited
Add to My Watchlist
3.33%
!
5.8¢

I would also suggest that Jane Shaw as a founder does not want...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.8¢ |
Change
-0.002(3.33%) |
Mkt cap ! $21.22M |
Open | High | Low | Value | Volume |
6.0¢ | 6.0¢ | 5.8¢ | $11.44K | 195.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 41323 | 5.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 1802 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 41323 | 0.057 |
1 | 180000 | 0.056 |
1 | 19605 | 0.051 |
1 | 20000 | 0.050 |
1 | 20000 | 0.047 |
Price($) | Vol. | No. |
---|---|---|
0.058 | 1802 | 1 |
0.059 | 20130 | 1 |
0.060 | 68334 | 1 |
0.064 | 10000 | 1 |
0.065 | 239790 | 1 |
Last trade - 15.42pm 31/07/2025 (20 minute delay) ? |
Featured News
BDX (ASX) Chart |